Continuation or maintenance ECT for schizophrenia: A narrative review of case report data

Australas Psychiatry. 2024 Aug;32(4):309-313. doi: 10.1177/10398562241256837. Epub 2024 May 28.

Abstract

Objective: This review aimed to address the limited evidence on the efficacy of continuation or maintenance electroconvulsive therapy (C/M-ECT) in schizophrenia, with a focus on international case reports and series due to the scarcity of randomised controlled trials.

Materials and methods: Electronic database searches were conducted to identify case reports or series evaluating the efficacy of C/M-ECT in patients with schizophrenia or schizoaffective disorder.

Results: C/M-ECT treatment span varied from 3 months to 36 years (Median = 30 months; M = 43.9 months; SD = 63.0) and was effective in maintaining remission for most patients with schizophrenia in combination with antipsychotic medication. Reporting of adverse events including cognitive adverse effects was infrequent.

Conclusions: Collation of case reports and series data indicated that C/M-ECT, when combined with antipsychotics, appears to be a safe and effective strategy for maintaining remission, even over several years. Caution is warranted due to the potential influence of publication bias.

Keywords: continuation electroconvulsive therapy; electroconvulsive therapy; maintenance electroconvulsive therapy; review; schizophrenia.

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Combined Modality Therapy
  • Electroconvulsive Therapy* / methods
  • Humans
  • Schizophrenia* / drug therapy
  • Schizophrenia* / therapy

Substances

  • Antipsychotic Agents